These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3199300)

  • 1. Effect of surface active agents on drug release from polylactic acid-hydrocortisone microcapsules.
    Leelarasamee N; Howard SA; Ma JK
    J Microencapsul; 1988; 5(1):37-46. PubMed ID: 3199300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of drug release from polylactic acid-hydrocortisone microcapsules.
    Leelarasamee N; Howard SA; Malanga CJ; Luzzi LA; Hogan TF; Kandzari SJ; Ma JK
    J Microencapsul; 1986; 3(3):171-9. PubMed ID: 3508185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A method for the preparation of polylactic acid microcapsules of controlled particle size and drug loading.
    Leelarasamee N; Howard SA; Malanga CJ; Ma JK
    J Microencapsul; 1988; 5(2):147-57. PubMed ID: 3199303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microencapsulation using poly(L-lactic acid) IV: Release properties of microcapsules containing phenobarbitone.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(1):53-66. PubMed ID: 2308054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control release of prostaglandin E2 from polylactic acid microcapsules, microparticles and modified microparticles.
    Zhou MX; Chang TM
    J Microencapsul; 1988; 5(1):27-36. PubMed ID: 3199299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microencapsulation and controlled release of insulin from polylactic acid microcapsules.
    Lin SY; Ho LT; Chiou HL
    Biomater Med Devices Artif Organs; 1985-1986; 13(3-4):187-201. PubMed ID: 3915873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of polylactic acid microcapsules containing ciprofloxacin.
    Yu WP; Wong JP; Chang TM
    J Microencapsul; 1998; 15(4):515-23. PubMed ID: 9651872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microencapsulation using poly(DL-lactic acid). III: Effect of polymer molecular weight on the release kinetics.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(3):357-74. PubMed ID: 2384838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled release captopril microcapsules: effect of non-ionic surfactants on release from ethyl cellulose microcapsules.
    Singh J; Robinson DH
    J Microencapsul; 1988; 5(2):129-37. PubMed ID: 3058925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microencapsulation using poly(DL-lactic acid). I: Effect of preparative variables on the microcapsule characteristics and release kinetics.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(2):229-44. PubMed ID: 2329448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microencapsulation using poly(DL-lactic acid). IV: Effect of storage on the microcapsule characteristics.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(3):375-83. PubMed ID: 2384839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained drug release characteristics of biodegradable composite poly(d,l)lactic acid-poly(l)lactic acid microcapsules containing ciprofloxacin.
    Yu WP; Wong JP; Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2000 Jan; 28(1):39-55. PubMed ID: 10676576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: influence of molecular weight and copolymer ratio of polymer.
    Ogawa Y; Yamamoto M; Takada S; Okada H; Shimamoto T
    Chem Pharm Bull (Tokyo); 1988 Apr; 36(4):1502-7. PubMed ID: 3138032
    [No Abstract]   [Full Text] [Related]  

  • 14. Poly(lactic acid) microencapsulated oxytetracycline: in vitro and in vivo evaluation.
    Vidmar V; Smolcić-Bubalo A; Jalsenjak I
    J Microencapsul; 1984; 1(2):131-6. PubMed ID: 6336522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of polylactic acid microcapsules containing prostaglandin E2 on the survival rates of grade II coma galactosamine induced fulminant hepatic failure rats.
    Zhou MX; Chang TM
    Biomater Artif Cells Artif Organs; 1987; 15(3):549-58. PubMed ID: 3481554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microencapsulation using poly(L-lactic acid). I: Microcapsule properties affected by the preparative technique.
    Jalil R; Nixon JR
    J Microencapsul; 1989; 6(4):473-84. PubMed ID: 2585239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microencapsulation of indomethacin by gelatin-acacia complex coacervation in the presence of surfactants.
    Tirkkonen S; Turakka L; Paronen P
    J Microencapsul; 1994; 11(6):615-26. PubMed ID: 7884626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and physical evaluation of microcapsules of hydrophilic drug-cyclodextrin complexes.
    Loftsson T; Kristmundsdóttir T; Ingvarsdóttir K; Olafsdóttir BJ; Baldvinsdóttir J
    J Microencapsul; 1992; 9(3):375-82. PubMed ID: 1403488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(3):297-325. PubMed ID: 2200861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eudragit RS and RL (acrylic resins) microcapsules as pH insensitive and sustained release preparations of ketoprofen.
    Goto S; Kawata M; Nakamura M; Maekawa K; Aoyama T
    J Microencapsul; 1986; 3(4):293-304. PubMed ID: 3508190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.